Mankind Pharma has completed the sale of its entire stake in Broadway Hospitality Services Private Limited to AKRK Projects LLP. The transaction closed on August 31, 2026, marking a full exit from the hospitality venture.

Transaction overview

The pharmaceutical company transferred its 100% shareholding in Broadway Hospitality to AKRK Projects and its partners. Consequently, Broadway ceased to be a wholly owned subsidiary of Mankind Pharma with effect from August 31, 2026.

This final update follows an earlier intimation dated July 11, 2026, which disclosed the initial details of the proposed divestment under Regulation 30 and 51 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Regulatory compliance

The company confirmed that all details required under the applicable Listing Regulations, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, were submitted with the earlier July 11 disclosure.

Mankind Pharma announced that Mr. Bharat Anand has ceased to be an Independent Director effective August 30, 2026. The departure follows the completion of his second term in office.

Mr. Anand, identified by DIN 02806475, also stepped down from membership in four key Board Committees. These include the Audit Committee, Nomination and Remuneration Committee, Risk Management Committee, and Corporate Social Responsibility Committee.

Regulatory Disclosure

The company issued the intimation under Regulation 30 and Regulation 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing references SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Hitesh Kumar Jain, Company Secretary and Compliance Officer, signed the disclosure. The Board expressed appreciation for Mr. Anand’s contribution during his tenure.